Skip to main content
. 2019 Jan 29;10(5):1275–1287. doi: 10.7150/jca.28570

Figure 4.

Figure 4

Effects of chidamide or combined with icotinib on the receptor tyrosine kinase (PTK) signaling molecules in NSCLC cells. A-D, chidamide inhibition of PTK signaling molecules in HCC827, HCC827IR, A549 and H1975 cells (48h). E, chidamide or combined with icotinib inhibition of PTK signaling molecules in H1975 cells (48h). Experiment was repeated at least thrice. Control: DMSO. GAPDH was used as a loading control.